Literature DB >> 15198164

Impact of clinical and histopathological factors on outcome of Egyptian patients with crescentic glomerulonephritis.

A A El-Husseini1, A E El-Agroudy, F E Moustafa, M A Fouda, M A Sobh.   

Abstract

This study included 128 patients with crescentic glomerulonephritis (CGN) having sufficient clinical and histopathological data and were followed up in our institute for a mean period of 34 +/- 28 months. There were 49 males and 79 females with mean age 22.7 +/- 14 years. We studied the effect of clinical, laboratory and histopathological parameters on kidney function and patient survival at the end point of the study. The multivariate analysis revealed that serum creatinine at presentation, nephrotic range proteinuria during the follow up period, percentage of glomeruli affected by crescents, percentage of fibrous crescents and absence of cellular infiltration were significant risk factors affecting the kidney function at termination of the study. The only risk factor which correlated significantly with the patient mortality was the serum creatinine at last follows up.

Entities:  

Mesh:

Year:  2003        PMID: 15198164     DOI: 10.1023/b:urol.0000025607.41722.aa

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  11 in total

1.  The significance of extracapillary proliferation. Clinicopathological review of 60 patients.

Authors:  J A Whitworth; L Morel-Maroger; F Mignon; G Richet
Journal:  Nephron       Date:  1976       Impact factor: 2.847

2.  Profile of crescentic glomerulonephritis in Natal--a clinicopathological assessment.

Authors:  K B Parag; A D Naran; Y K Seedat; B C Nathoo; I P Naiker; S Naicker
Journal:  Q J Med       Date:  1988-08

3.  Prognosis after immunosuppression of patients with crescentic nephritis requiring dialysis.

Authors:  C R Hind; H Paraskevakou; C M Lockwood; D J Evans; D K Peters; A J Rees
Journal:  Lancet       Date:  1983-02-05       Impact factor: 79.321

4.  Immunopathology, extent and course of glomerulonephritis with crescent formation.

Authors:  U N Bhuyan; S C Dash; R N Srivastava; R K Sharma; K K Malhotra
Journal:  Clin Nephrol       Date:  1982-12       Impact factor: 0.975

Review 5.  Idiopathic rapidly progressive glomerulonephritis.

Authors:  W G Couser
Journal:  Am J Nephrol       Date:  1982       Impact factor: 3.754

6.  Biopsy proven evolution of post streptococcal glomerulonephritis to rapidly progressive glomerulonephritis of a post infectious type.

Authors:  D Modai; A Pik; M Behar; A Eidelman; Z Averbukh; J Weissgarten; D Gabizon; E Rosenmann
Journal:  Clin Nephrol       Date:  1985-04       Impact factor: 0.975

7.  Rapidly progressive glomerulonephritis: analysis of prevalence and clinical course.

Authors:  K Andrassy; S Küster; R Waldherr; E Ritz
Journal:  Nephron       Date:  1991       Impact factor: 2.847

8.  Rapidly progressive glomerulonephritis with extensive glomerular crescent formation.

Authors:  G H Neild; J S Cameron; C S Ogg; D R Turner; D G Williams; C B Brown; C Chantler; J Hicks
Journal:  Q J Med       Date:  1983

9.  Analysis of risk factors for patient and renal survival in crescentic glomerulonephritis.

Authors:  R L Heilman; K P Offord; K E Holley; J A Velosa
Journal:  Am J Kidney Dis       Date:  1987-02       Impact factor: 8.860

10.  A clinico-pathologic study of crescentic glomerulonephritis in 50 children. A report of the Southwest Pediatric Nephrology Study Group.

Authors: 
Journal:  Kidney Int       Date:  1985-02       Impact factor: 10.612

View more
  1 in total

1.  Crescentic glomerulonephritis in children: a single centre experience.

Authors:  Sare Gülfem Özlü; Aysun Çaltık; Özlem Aydoğ; Mehmet Bülbül; Gülay Demircin; Evrim Çakıcı; Nilüfer Arda; Ayşe Öner
Journal:  World J Pediatr       Date:  2015-12-18       Impact factor: 2.764

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.